These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 36532857)
1. A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2. Chaube U; Patel BD; Bhatt HG 3 Biotech; 2023 Jan; 13(1):12. PubMed ID: 36532857 [TBL] [Abstract][Full Text] [Related]
2. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach. Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539 [TBL] [Abstract][Full Text] [Related]
3. Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study. Gogoi M; Borkotoky M; Borchetia S; Chowdhury P; Mahanta S; Barooah AK J Biomol Struct Dyn; 2022 Sep; 40(15):7143-7166. PubMed ID: 33715595 [TBL] [Abstract][Full Text] [Related]
5. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study. Wakchaure PD; Ghosh S; Ganguly B J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493 [TBL] [Abstract][Full Text] [Related]
6. Strategic analyses to identify key structural features of antiviral/antimalarial compounds for their binding interactions with 3CLpro, PLpro and RdRp of SARS-CoV-2: Dhote AM; Patil VR; Lokwani DK; Amnerkar ND; Ugale VG; Charbe NB; Bhongade BA; Khadse SC J Biomol Struct Dyn; 2022; 40(22):11914-11931. PubMed ID: 34431452 [TBL] [Abstract][Full Text] [Related]
7. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach. Dhankhar P; Dalal V; Kumar V J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746 [TBL] [Abstract][Full Text] [Related]
8. De Novo Potent Peptide Nucleic Acid Antisense Oligomer Inhibitors Targeting SARS-CoV-2 RNA-Dependent RNA Polymerase via Structure-Guided Drug Design. Shehzadi K; Yu M; Liang J Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139312 [TBL] [Abstract][Full Text] [Related]
9. Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus. Tiwari V Int J Biol Macromol; 2021 Feb; 171():358-365. PubMed ID: 33421473 [TBL] [Abstract][Full Text] [Related]
10. State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2. Tanimoto S; Itoh SG; Okumura H Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142270 [TBL] [Abstract][Full Text] [Related]
11. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations. Nguyen HL; Thai NQ; Truong DT; Li MS J Phys Chem B; 2020 Dec; 124(50):11337-11348. PubMed ID: 33264025 [TBL] [Abstract][Full Text] [Related]
12. Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach. Singh R; Bhardwaj VK; Purohit R Comput Biol Med; 2021 Dec; 139():104965. PubMed ID: 34717229 [TBL] [Abstract][Full Text] [Related]
13. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase. Zhao J; Guo S; Yi D; Li Q; Ma L; Zhang Y; Wang J; Li X; Guo F; Lin R; Liang C; Liu Z; Cen S Antiviral Res; 2021 Jun; 190():105078. PubMed ID: 33894278 [TBL] [Abstract][Full Text] [Related]